1952.HK · EVEREST MED
Hong Kong · RS rating 67 · As of 2026-10-14
| Price | 31.88 HKD |
|---|---|
| 1-day change | -3.4% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 92 / 77 / 27 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 34 / 22 / 37 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +44.1% |
| Market cap (USD) | $1.3B |